Nerveblox AI Software Gains FDA Clearance for Regional Anesthesia
SmartAlpha's Nerveblox, an AI software designed to assist in ultrasound-guided regional anesthesia, has received FDA 510(k) clearance, announced in a press release. This clearance allows the company to introduce its technology to the U.S. healthcare market.
Nerveblox aids healthcare professionals by detecting and highlighting 50 key anatomical structures in real-time during ultrasound scanning for nerve block procedures. These procedures are used to manage surgical and chronic pain by numbing localized regions, potentially reducing the need for opioids and leading to faster recovery times.
The software supports a wide range of clinical practices, including cesarean sections, breast surgery, and knee and shoulder procedures. SmartAlpha, a Türkiye-based startup, is now focused on expanding its commercialization efforts and building partnerships to ensure the global reach of Nerveblox. The software has also received regulatory approvals in Europe, the UK, and Australia earlier this year.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 30 Insilico Medicine Selects AI Designed Obesity Drug Candidate ISM1354 Sep 29 Truven launches MarketScan Snapshot for healthcare data checks Sep 29 Omega Healthcare Wins Gold in 2026 AI Breakthrough Awards Sep 29 Phylo Launches Target Atlas for Drug Target Prioritization Sep 29 ChromAgeNet Detects Aging Signs in Blood Stem Cell ImagesLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Norbert Health Raises $14 Million for Robotic Nursing Assistants
Brainomix Selected for UK Future Fifty Programme
World Class Health Introduces AI Specialty Clinic
Noma Security Named Market Shaper in Gartner AI Security Quadrant
CluePoints Releases Three AI Tools for Clinical Data Review
Daily AI Brief: the AI news that matters, in your inbox.